Language Log

A cartoonist and her collaborator have been arrested in China for being "spiritually Japanese" (jīng Rì 精日).  They have also been accused of "insulting China" (rǔ Huá 辱华).  The latter term is transparent, and I've been hearing it a lot for the last couple of decades, whereas the former term is morphologically more difficult to understand (lit., "spirit Ja[pan]") and is new to me.

• "Chinese Cartoonist, Collaborator Arrested for Unpatriotic Comics:  Authorities say the pair shared hundreds of comics online that ‘twisted Chinese history’", Hoi Ying Lo, Sixth Tone (7/30/19)
• "Chinese cartoonist detained by police for ‘insulting China’", Qin Chen, Inkstone News (7/31/19)

In "Contextualized Muppet Embeddings" (2/13/2019) I noted the advent of ELMo ("Embeddings from Language Models") and BERT ("Bidirectional Encoder Representations from Transformers"), and predicted ERNiE, GRoVEr, KERMiT, …

I'm happy to say that the first of these predictions has come true:

"Baidu’s ERNIE 2.0 Beats BERT and XLNet on NLP Benchmarks", Synced 7/30/2019
"Baidu unveils ERNIE 2.0 natural language framework in Chinese and English", VentureBeat 7/30/2019

Actually I'm late reporting this, since ERNIE 1.0 came out in March:

"Baidu’s ERNIE Tops Google’s BERT in Chinese NLP Tasks", Synced 3/25/2019

But I'm ashamed to say that the Open System for Classifying Ambiguous Reference (OSCAR) is still just an idea, though I did recruit a collaborator who agreed in principle to work with me on it.

So, kurzgesagt, reads the text that runs along all four sides of this two-millennia-old iron writing instrument excavated from an archeological site in London six years ago:

"FDA approves first novel drug to treat medical burnout":

TWISP, WA – The US Food and Drug Administration today approved Peaceaudi (Idongivafumab) injection for intravenous use for the treatment of medical burnout.

“Medical burnout is a serious condition, which affects thousands of doctors across the country. The effects of burnout have untold consequences, and could significantly shorten the careers of physicians if untreated,” said Arnold J. Palmer, MD, assistant to the regional manager for drug development of the FDA.

“This announcement marks the first time a drug has been specifically approved to treat medical burnout. Idongivafumab’s unique ability to target and inhibit C-suite peptides, as well the entire electronic health record (EHR) cascade, represents a quantum leap in burnout science."